IDH1 and glioblastoma: Within the training cohort of GBM patients from the TCGA, the nomogram and PRSM were constructed based on the combination of Loxl1 and clinicopathological parameters, including age, IDH mutation status, chemotherapy, and radiotherapy (Fig. 5A).